Cargando…

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance

Long-acting glucagon-like peptide 1 receptor agonists are increasingly used to treat type 2 diabetes. An increase of heart rate (HR) has been observed with their use. To elucidate the role of the cardiac sympatho-vagal balance as a possible mediator of the reported increase in HR, we performed power...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cacciatori, Vittorio, Zoppini, Giacomo, Bellavere, Federico, Rigolon, Riccardo, Thomaseth, Karl, Pichiri, Isabella, Trombetta, Maddalena, Dauriz, Marco, De Santi, Francesca, Targher, Giovanni, Santi, Lorenza, Bonora, Enzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779107/ https://www.ncbi.nlm.nih.gov/pubmed/29379894 http://dx.doi.org/10.1210/js.2017-00300

Ejemplares similares

Lower levels of 25-hydroxyvitamin D(3) are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2015)

Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9
por: Bonora, Enzo, et al.
Publicado: (2020)

Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
por: Mantovani, Alessandro, et al.
Publicado: (2017)

Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10
por: Bonora, Enzo, et al.
Publicado: (2022)

Cardiac sympatho-vagal balance and ventricular arrhythmia()
por: Kalla, Manish, et al.
Publicado: (2016)

The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2016)

Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
por: Zoppini, Giacomo, et al.
Publicado: (2012)

The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Sympatho-Vagal Imbalance is Associated with Sarcopenia in Male Patients with Heart Failure
por: da Fonseca, Guilherme Wesley Peixoto, et al.
Publicado: (2019)

Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
por: Rodrigues, Gabriel Dias, et al.
Publicado: (2022)

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2020)

The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance
por: Billman, George E.
Publicado: (2013)

Heart Rate Kinetics and Sympatho-Vagal Balance Accompanying a Maximal Sprint Test
por: Storniolo, Jorge L., et al.
Publicado: (2020)

Sympatho–Vagal Dysfunction in Patients with End-Stage Lung Disease Awaiting Lung Transplantation
por: Tobaldini, Eleonora, et al.
Publicado: (2020)

Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2012)

Resting sympatho-vagal balance is related to 10 km running performance in master endurance athletes
por: Cataldo, Angelo, et al.
Publicado: (2018)

Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers
por: Acampa, Maurizio, et al.
Publicado: (2018)

Modulation of the Sympatho-Vagal Balance during Sleep: Frequency Domain Study of Heart Rate Variability and Respiration
por: Cabiddu, Ramona, et al.
Publicado: (2012)

The influence of oral water load on energy expenditure and sympatho-vagal balance in obese and normal weight women
por: Kocełak, Piotr, et al.
Publicado: (2012)

Atrial fibrillation and sympatho–vagal imbalance: from the choice of the antiarrhythmic treatment to patients with syncope and ganglionated plexi ablation
por: Rebecchi, Marco, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2015)

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial
por: Haarmann, Helge, et al.
Publicado: (2016)

Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population
por: De Santi, F., et al.
Publicado: (2017)

Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2009)

SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people
por: Bonora, Enzo, et al.
Publicado: (2021)

Sympatho-renal axis in chronic disease
por: Sobotka, Paul A., et al.
Publicado: (2011)

High-Normal HbA(1c) Is a Strong Predictor of Type 2 Diabetes in the General Population
por: Bonora, Enzo, et al.
Publicado: (2011)

Mechanisms of the Blunting of the Sympatho-Adrenal Response: A Theory
por: Parekh, B
Publicado: (2009)

Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Rossi, Andrea, et al.
Publicado: (2012)

Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology
por: Du, Xiaojun
Publicado: (2021)

Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes
por: Ridge, T, et al.
Publicado: (2012)

Acute changes in forearm vascular compliance during transient sympatho‐excitation
por: Olver, T. Dylan, et al.
Publicado: (2022)

The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
por: Andreozzi, Francesco, et al.
Publicado: (2016)

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
por: Mitchell, James L, et al.
Publicado: (2023)

Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
por: Ludwig, Mette Q., et al.
Publicado: (2021)

Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages
por: Bułdak, Łukasz, et al.
Publicado: (2015)

Region-specific sympatho-adrenergic regulation of specialized vasculature in bone homeostasis and regeneration
por: Xu, Hao-Kun, et al.
Publicado: (2023)

Diabetes as a cause of death across different COVID-19 epidemic waves
por: Fedeli, Ugo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cqg5p1kbqlhth5dtmakk65iipa